Global Cell Therapy Market 2023-2027

Description

List of Tables

The cell therapy market is forecasted to grow by USD 31,041.49 mn during 2022-2027, accelerating at a CAGR of 57.06% during the forecast period. The report on the cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by limitations in traditional organ transplantations fueling demand for cell therapies, increasing funding in cell-based research, and proven effectiveness of CAR T-cell therapy.

Technavio's cell therapy market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	56.5%
CAGR	57.06%
Incremental Value	$31041.49mn

By Type

Autologous
Allogenic

By Application

Malignancies
Musculoskeletal
Cardiovascular
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing focus on cell therapy products as one of the prime reasons driving the cell therapy market growth during the next few years. Also, strategic alliances in cell therapy market and rise in vaccine production will lead to sizable demand in the market.

The report on the cell therapy market covers the following areas:

Cell therapy market sizing
Cell therapy market forecast
Cell therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell therapy market vendors that include Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc. Also, the cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72148

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global cell therapy market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global cell therapy market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Autologous - Market size and forecast 2022-2027
Exhibit 34: Chart on Autologous - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Autologous - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Autologous - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Autologous - Year-over-year growth 2022-2027 (%)
6.4 Allogenic - Market size and forecast 2022-2027
Exhibit 38: Chart on Allogenic - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Allogenic - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Allogenic - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Allogenic - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Malignancies - Market size and forecast 2022-2027
Exhibit 48: Chart on Malignancies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Malignancies - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Malignancies - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Malignancies - Year-over-year growth 2022-2027 (%)
7.4 Musculoskeletal - Market size and forecast 2022-2027
Exhibit 52: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
7.5 Cardiovascular - Market size and forecast 2022-2027
Exhibit 56: Chart on Cardiovascular - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Cardiovascular - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Cardiovascular - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Cardiovascular - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Application
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 115: Astellas Pharma Inc. - Overview
Exhibit 116: Astellas Pharma Inc. - Product / Service
Exhibit 117: Astellas Pharma Inc. - Key news
Exhibit 118: Astellas Pharma Inc. - Key offerings
12.4 Athersys Inc.
Exhibit 119: Athersys Inc. - Overview
Exhibit 120: Athersys Inc. - Product / Service
Exhibit 121: Athersys Inc. - Key offerings
12.5 Avita Medical Inc.
Exhibit 122: Avita Medical Inc. - Overview
Exhibit 123: Avita Medical Inc. - Product / Service
Exhibit 124: Avita Medical Inc. - Key offerings
12.6 BioCardia Inc.
Exhibit 125: BioCardia Inc. - Overview
Exhibit 126: BioCardia Inc. - Product / Service
Exhibit 127: BioCardia Inc. - Key offerings
12.7 BioSenic SA
Exhibit 128: BioSenic SA - Overview
Exhibit 129: BioSenic SA - Product / Service
Exhibit 130: BioSenic SA - Key offerings
12.8 Brainstorm Cell Therapeutics Inc.
Exhibit 131: Brainstorm Cell Therapeutics Inc. - Overview
Exhibit 132: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibit 133: Brainstorm Cell Therapeutics Inc. - Key offerings
12.9 Bristol Myers Squibb Co.
Exhibit 134: Bristol Myers Squibb Co. - Overview
Exhibit 135: Bristol Myers Squibb Co. - Product / Service
Exhibit 136: Bristol Myers Squibb Co. - Key news
Exhibit 137: Bristol Myers Squibb Co. - Key offerings
12.10 Capricor Therapeutics Inc.
Exhibit 138: Capricor Therapeutics Inc. - Overview
Exhibit 139: Capricor Therapeutics Inc. - Product / Service
Exhibit 140: Capricor Therapeutics Inc. - Key offerings
12.11 Castle Creek Biosciences Inc.
Exhibit 141: Castle Creek Biosciences Inc. - Overview
Exhibit 142: Castle Creek Biosciences Inc. - Product / Service
Exhibit 143: Castle Creek Biosciences Inc. - Key offerings
12.12 CellSeed Inc.
Exhibit 144: CellSeed Inc. - Overview
Exhibit 145: CellSeed Inc. - Product / Service
Exhibit 146: CellSeed Inc. - Key offerings
12.13 Cellular Biomedicine Group Inc.
Exhibit 147: Cellular Biomedicine Group Inc. - Overview
Exhibit 148: Cellular Biomedicine Group Inc. - Product / Service
Exhibit 149: Cellular Biomedicine Group Inc. - Key offerings
12.14 Celyad Oncology SA
Exhibit 150: Celyad Oncology SA - Overview
Exhibit 151: Celyad Oncology SA - Product / Service
Exhibit 152: Celyad Oncology SA - Key offerings
12.15 Gilead Sciences Inc.
Exhibit 153: Gilead Sciences Inc. - Overview
Exhibit 154: Gilead Sciences Inc. - Product / Service
Exhibit 155: Gilead Sciences Inc. - Key news
Exhibit 156: Gilead Sciences Inc. - Key offerings
12.16 Lineage Cell Therapeutics Inc.
Exhibit 157: Lineage Cell Therapeutics Inc. - Overview
Exhibit 158: Lineage Cell Therapeutics Inc. - Product / Service
Exhibit 159: Lineage Cell Therapeutics Inc. - Key offerings
12.17 Lisata Therapeutics Inc.
Exhibit 160: Lisata Therapeutics Inc. - Overview
Exhibit 161: Lisata Therapeutics Inc. - Product / Service
Exhibit 162: Lisata Therapeutics Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 165: Currency conversion rates for US$
13.4 Research methodology
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
13.5 List of abbreviations
Exhibit 169: List of abbreviations